CD47: a potential immunotherapy target for eliminating cancer cells.
about
Breast cancers from black women exhibit higher numbers of immunosuppressive macrophages with proliferative activity and of crown-like structures associated with lower survival compared to non-black Latinas and Caucasians.Anti-leukemic activity and tolerability of anti-human CD47 monoclonal antibodies.Expanding Diversity and Common Goal of Regulatory T and B Cells. II: In Allergy, Malignancy, and Transplantation.CD47-CAR-T Cells Effectively Kill Target Cancer Cells and Block Pancreatic Tumor Growth.Calreticulin: Challenges Posed by the Intrinsically Disordered Nature of Calreticulin to the Study of Its Function.Eviction from the sanctuary: Development of targeted therapy against cell adhesion molecules in acute lymphoblastic leukemia.Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site.Rhesus CE expression on patient red blood cells is an independent prognostic factor for adenocarcinoma of the lung.
P2860
Q37456793-ABC98082-8B08-4364-8995-C2A813BDA2DEQ37744822-E5CF79F7-6E90-470D-83BC-93873D7DCB38Q39282520-C6A1D8B0-9853-4CC7-8E93-C2B342FFF8DBQ47121255-8ACE4A31-A62A-49A8-BD93-135D8B66E69EQ47317019-387B97CB-2400-4652-8BB2-17138593BC38Q47783708-A64BA66C-3A93-4EB1-B301-6188D0A8F827Q47963534-018158B8-CD2A-4AA0-A437-EC440927D6BCQ54301102-4A4EECA0-56A7-42AA-8277-D66E1157B2FB
P2860
CD47: a potential immunotherapy target for eliminating cancer cells.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
CD47: a potential immunotherapy target for eliminating cancer cells.
@en
type
label
CD47: a potential immunotherapy target for eliminating cancer cells.
@en
prefLabel
CD47: a potential immunotherapy target for eliminating cancer cells.
@en
P2093
P2860
P1476
CD47: a potential immunotherapy target for eliminating cancer cells.
@en
P2093
P2860
P2888
P304
P356
10.1007/S12094-016-1489-X
P577
2016-02-01T00:00:00Z